MBM's Regulatory Practice Group

MBM services single regulatorypractice

MBM's Regulatory Practice Group advises clients on a broad range of regulatory issues related to drugs, natural health products, medical devices/diagnostics, food and cosmetics.  It is comprised of a multidisciplinary group of practitioners with past experience working at Health Canada in the application and enforcement of the Food & Drug Act and associated regulations, as well as working within major pharmaceutical companies:

Our expertise includes, but is not limited to, the following:

  • Classification of products under the various regulatory regimes;
  • Manoeuvring through the regulatory approval process including pre-submission and submission activities with regulatory authorities and appeals of submission decisions;
  • Patent listing under the Patented Medicines (Notice of Compliance) Regulations and eligibility for data protection/exclusivity; and
  • Application of the Patented Medicine Prices Review Board and formulary listing and reimbursement. 

 

 

Submit to DiggSubmit to FacebookSubmit to Google BookmarksSubmit to StumbleuponSubmit to TwitterSubmit to LinkedIn

cb photo 111 561d6b13433c5JONATHAN ROCH

Partner

Jonathan assists clients with their intellectual property rights including patents, trademarks, copyrights, industrial designs and trade secretsMBM read_more_btn

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Protecting Plant Varieties in Canada

Protection for new plant varieties has been available for just over twenty years in Canada.  As new technologies are sought for increasing and improving crop production, Plant Breeders’ Rights help to encourage such innovation by rewarding plant breeders with exclusive rights to sell, and to produce for sale, the reproductive material of their new plant variety. Read More